Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 15.08 Delayed Data As of Jun 28 |  -1.10 / -6.80%Today’s Change | 11.70 Today|||52-Week Range 65.00 | -59.25% Year-to-Date |
Latest ARCT News | Press Releases
No recent news for Arcturus Therapeutics Holdings Inc.
Today’s Trading
| Previous close | 16.17 |
| Today’s open | 16.28 |
| Day’s range | 14.81 - 16.37 |
| Volume | 400,673 |
| Average volume (3 months) | 689,690 |
| Market cap | $426.4M |
Data as of 4:00pm ET, 06/28/2022
Growth & Valuation
| Earnings growth (last year) | -117.81% |
| Earnings growth (this year) | +7.59% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +29.56% |
| P/E ratio | NM |
| Price/Sales | 78.81 |
| Price/Book | 1.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AFMDAffimed NV | -0.14 | -4.79% |
| ---- | ||
| ESPREsperion Therapeutic... | -0.28 | -4.27% |
| INOInovio Pharmaceutica... | -0.13 | -6.67% |
Data as of 4:00pm ET, 06/28/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$1.88 |
| Annual revenue (last year) | $12.4M |
| Annual profit (last year) | -$203.7M |
| Net profit margin | -1,647.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
